{
    "clinical_study": {
        "@rank": "13214", 
        "acronym": "OxyTarget", 
        "arm_group": {
            "arm_group_label": "Rectal cancer"
        }, 
        "biospec_descr": {
            "textblock": "Blood, rectal cancer tissue, normal tissue, lymph nodes"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to establish a reliable method for detection of rectal cancer\n      patients with aggressive tumor at risk of metastatic disease and death by functional MRI."
        }, 
        "brief_title": "Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Rectal Diseases", 
            "Rectal Neoplasms", 
            "Gastrointestinal Diseases", 
            "Gastrointestinal Neoplasms"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Aggression", 
                "Neoplasms", 
                "Rectal Neoplasms", 
                "Gastrointestinal Diseases", 
                "Digestive System Diseases", 
                "Gastrointestinal Neoplasms", 
                "Digestive System Neoplasms", 
                "Rectal Diseases", 
                "Anoxia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient is willing and able to give full written consent according to the\n             protocol approved by the Regional Ethics Committee.\n\n          -  The patient has confirmed rectal cancer diagnosis and is scheduled to radical surgery\n             alone or preoperative CRT followed by surgery.\n\n          -  The patient is \u2265 18 years.\n\n          -  The patient has no prior rectal cancer treatment.\n\n          -  The patient has adequate renal function: creatinine clearance \u2265 60 ml/minute.\n\n          -  The patient has signed the written informed consent according to the protocol\n             approved by the Regional Ethics Committee.\n\n        Exclusion Criteria:\n\n          -  The patient has contraindication to MRI or MRI contrast agent according to clinical\n             practice.\n\n          -  The patient wants to withdraw for any reason during the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Rectal cancer patients referred to radical surgery, with or without preoperative\n        chemoradiotherapy."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01816607", 
            "org_study_id": "REK-2013/152", 
            "secondary_id": "REK-2013/152"
        }, 
        "intervention": {
            "arm_group_label": "Rectal cancer", 
            "description": "diffusion-weighted MRI, dynamic-contrast enhanced MRI, MR spectroscopy, blood-level oxygen dependent (BOLD) MRI", 
            "intervention_name": "new functional magnetic resonance imaging (MRI) protocols", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Magnetic Resonance Imaging", 
            "Magnetic Resonance Imaging, Functional"
        ], 
        "lastchanged_date": "November 7, 2013", 
        "location": {
            "contact": {
                "email": "kathrine.roe@medisin.uio.no", 
                "last_name": "Kathrine R\u00f8e, PhD", 
                "phone": "+4792437646"
            }, 
            "facility": {
                "address": {
                    "city": "L\u00f8renskog", 
                    "country": "Norway", 
                    "state": "Akershus", 
                    "zip": "1478"
                }, 
                "name": "Akershus University Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Kathrine R\u00f8e, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Anne H Ree, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Anne Neg\u00e5rd, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Arne S Borthne, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Arne E F\u00e6rden, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Solveig N Andersen, MD, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_groups": "1", 
        "official_title": "Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness", 
        "other_outcome": {
            "measure": "Detection of regional malignant lymph nodes at time of diagnosis", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "overall_contact": {
            "email": "kathrine.roe@ahus.no", 
            "last_name": "Kathrine R\u00f8e, PhD", 
            "phone": "+4792437646"
        }, 
        "overall_contact_backup": {
            "email": "a.h.ree@medisin.uio.no", 
            "last_name": "Anne H Ree, MD, PhD"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Akershus", 
            "last_name": "Kathrine R\u00f8e, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Norway:National Committee for Medical and Health Research Ethics", 
                "Norway: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Presence of metastatic disease 5 years after rectal cancer treatment", 
            "safety_issue": "No", 
            "time_frame": "five years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01816607"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Akershus", 
            "investigator_full_name": "Kathrine R\u00f8e", 
            "investigator_title": "Postdoctoral researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Histomorphological response to preoperative chemoradiotherapy", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "source": "University Hospital, Akershus", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Oslo University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Oslo", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University Hospital, Akershus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}